Join us in a live Webinar!
Please join us in one a webinar session for a live demonstration of Nexus Copy Number for analysis of head and neck cancer using Empire Genomics High Resolution aCGH Arrays.
In this webinar we will show how Nexus Copy Number Professional was used to analyze aCGH data from Head and Neck Carcinoma samples processed on Empire Genomics' Human ACCUArray platform. Head and neck cancers account for 3-5% of all cancers in the US. Tobacco and alcohol are the most common risk factors. Mutations in p53 and HPV are some other factors implicated in certain head and neck cancers. The samples used in this study consisted of 53 fresh frozen tissues and eight FFPE samples forming a set of 61 samples in. Using Nexus Copy Number Professional, we will demonstrate how the raw data can be transformed into biological insights in a few minutes. We will show how we have been able to identify regions that have differences in copy number between HPV positive and HPV negative samples and how the aberration profile generated correlated very well with previously published results. We will demonstrate how we were able to integrate GO annotations to discover that one of the highly ranked GO Biological Processes is the cell cycle checkpoint process. Clustering of samples based on aberrations and association with survival will also be covered.
Dr. Norma Nowak named an AACR 2008 Team Science Award Winner
 |
 |
| Click to enlarge |
Empire Genomics Founder Dr. Norma Nowak, along with 11 other experts in the field, have been honored for their active roles in the conception, technical implementation, dissemination and pioneering applications of comparative genomic hybridization (CGH) and array CGH.
This Award has been established by the American Association for Cancer Research and Eli Lilly and Company to acknowledge and catalyze the growing importance of interdisciplinary teams to the understanding of cancer and/or the translation of research discoveries into clinical cancer applications. Proactive interaction between academic and industry researchers is particularly crucial to continue progress and accelerate drug development.
Click here to read more
Empire Genomics Names Leading Genetic Researchers and Industry Experts to Scientific Advisory Board
The members of the new SAB represent a combination of scientific and medical expertise and clinical and operational experience in molecular genetics that will support the company as it develops diagnostic and research technologies for cancer biology, biomarkers, drug discovery, prenatal screening, developmental disorders, autism and other genomic related areas.
Click here to read more
Empire Genomics And Reprogenetics Join Forces To Improve Preimplantation Genetic Diagnosis (PGD)
Data on Successful Use of New PGD Technique to be Presented at American Society for Reproductive Medicine (ASRM) Annual Meeting. Improved Techniques Could Lead to Improved Overall Pre-natal Screening for Spontaneous Pregnancies as well as PGD with In Vitro Fertilization.
Click here to read more
Benefits Point Biotech Firms to Buffalo
Research Spending Increased 43% in Five Years.
Click here to read more
23 chosen for Bizwomen Award
Dr. Norma Nowak, Founder & CSO of Empire Genomics among award recipients.
Click here to read more
PersonaDX shows off lab for cancer tests
Firm is one of three spinoff businesses from Roswell Park.
Click here to read more
Affymetrix Enters Into Licensing Deal With Empire Genomics - Quick Facts
Click here to read more
Affymetrix licenses patents to Empire Genomics
Click here to read more
Empire Genomics creates jobs for Western New York
Empire Genomics featured on News Channel 4
Empire Genomics joins booming medical corridor
Click here to read more
Business First discusses Empire Genomics Test for Chromosomal Defects
Click here to read more
Empire Genomics discovers the smallest accurately defined duplication of chromosome 21 reported with a Down syndrome (DS) phenotype.
Click here to read more
Agilent Technologies announces it has signed Empire Genomics as Certified Microarray Service Provider
Click here to read more
Population Diagnostics and Empire Genomics to Create Expansive Relationship for Large Scale Molecular Diagnostics & Personalized Medicine Development Program
Click here to read more
